Siglec-F Protects Against Elastase-induced Lung Inflammation and Emphysema in Mice
Authors:
- Qihua YeQYQihua Ye
- Yan HuYHYan Hu
- Marika OrlovMOMarika Orlov
- Bradford J. SmithBSBradford J. Smith
- Tonya M BrunettiTBTonya M Brunetti
- Rachel Z BlumhagenRBRachel Z Blumhagen
- Zhenghui LiuZLZhenghui Liu
- Melanie KönigshoffMKMelanie Königshoff
- William J. JanssenWJWilliam J. Janssen
- Christopher M. EvansCEChristopher M. Evans
Preprint
Abstract
Respiratory surfaces are exposed daily to billions of inhaled particles that could cause injury to alveolar tissues where gas exchange occurs. Accordingly, robust defense is essential but must involve minimal physiologic disruption. Airspace macrophages (AMs) protect lung surfaces while also maintaining tissue integrity through non-inflammatory homeostatic responses in health. However, in chronic obstructive pulmonary disease (COPD), AMs contribute to emphysematous alveolar destruction through mechanisms that are poorly understood. We hypothesized that damaging effects of AMs in emphysema result from loss of mechanisms that normally restrain homeostatic AMs. We found that Siglec-F, a common marker of AMs, exerts suppressive effects on tissue resident AMs (RAMs), thereby supporting alveolar integrity in mouse lungs during health and in a model of elastase-induced alveolar destruction. Siglec-F-deficient mice exhibited decreased alveolar numbers at baseline, and they had worsened alveolar damage after elastase challenge that was unexpectedly RAM-mediated. Transcriptomic profiling revealed dysregulation of key pathways involved in tissue remodeling and repair, including extracellular matrix degradation, TGF-β signaling, and phagocytosis. These findings uncover previously unrecognized roles for RAMs and Siglec-F in preserving alveolar integrity. Our findings implicate RAMs and Siglecs as potential therapeutic targets for preserving alveolar integrity in health and for limiting alveolar damage in COPD.Keywords
Funding Information
- NIH (K99HL161446)
- NIH (R01HL151630)
- NIH (F32HL172725)
- NIH (R01HL14974)
- NIH (R35HL140039)
- NIH (R01HL130938)
- NIH (R01HL080396)
- NIH (P01HL162607)
- VA (I01BX005343)
This publication has 43 references indexed in Scilit:
- Cigarette Smoke Impairs Clearance of Apoptotic Cells through Oxidant-dependent Activation of RhoAAmerican Journal of Respiratory and Critical Care Medicine, 2009
- Developmental alveolarization of the mouse lungDevelopmental Dynamics, 2008
- Pathogenesis of COPD. Part I. The role of protease-antiprotease imbalance in emphysema.2008
- SOCS3 Targets Siglec 7 for Proteasomal Degradation and Blocks Siglec 7-mediated ResponsesJournal of Biological Chemistry, 2007
- Alveolar macrophages from subjects with chronic obstructive pulmonary disease are deficient in their ability to phagocytose apoptotic airway epithelial cellsImmunology & Cell Biology, 2003
- Loss of integrin αvβ6-mediated TGF-β activation causes Mmp12-dependent emphysemaNature, 2003
- Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-β1 secretion and the resolution of inflammationJournal of Clinical Investigation, 2002
- Severity of Elastase-Induced Emphysema Is Decreased in Tumor Necrosis Factor-α and Interleukin-1β Receptor-Deficient MiceLaboratory Investigation, 2002
- Transforming Growth Factor-β1 Inhibition of Macrophage Activation Is Mediated via Smad3Journal of Biological Chemistry, 2000
- Transforming Growth Factor-β1 Inhibits Cytokine-mediated Induction of Human Metalloelastase in MacrophagesJournal of Biological Chemistry, 2000